InsiderTradr

Lyka Labs Limited (LYKALABS.BO)

BSE · INR · Healthcare · Biotechnology

₹80.24 (-1.99%) as of

Key statistics

Market cap
2.86B
P/E (TTM)
136.00
EPS (TTM)
0.59
52-week range
68.57 – 143.80
Beta
0.16
Revenue (TTM)
1.3B
Profit margin
-0.50%
Volume
136.00

About Lyka Labs Limited

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant tablets and combination, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, anti-fungal and bacterial, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.

Sector
Healthcare
Industry
Biotechnology
Headquarters
Mumbai, India
Employees
499

lykalabs.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks